Prostate Cancer Early Detection

The Prostate Cancer Early Detection guidelines do not address the treatment of prostate cancer. It is the majority opinion of the
Prostate Cancer Early Detection panel members that there is a growing population of men currently being diagnosed with
prostate cancer who can, and should, be monitored for their disease as presented in the Prostate Cancer Treatment Guidelines.
The guidelines for a baseline PSA and lowering the PSA thresholds for biopsy were recommended by most panel members, but
a consensus was not reached.


The guidelines are continuously in a state of evolution and the panel will incorporate changes based on new evidence and
expert opinion and provide a rating of consensus with respect to each recommendation.